LC, d. C., RCBDS, T., M, I., SC, M., MCR, M., MC, N., . . . PCJL, S. (2026). Tacrolimus Concentration/Dose Ratio in Hematopoietic Cell Transplantation Recipients: An Exploratory Study of Metabolizer Phenotyping and Clinical Outcomes. Clinical and translational science, 19(6), e70637. https://doi.org/10.1111/cts.70637
Chicago Style (17th ed.) CitationLC, da Costa-Junior, Tavares RCBDS, Izu M, Maradei SC, Moreira MCR, Nogueira MC, Lerner D, de Souza Fernandez T, and Santos PCJL. "Tacrolimus Concentration/Dose Ratio in Hematopoietic Cell Transplantation Recipients: An Exploratory Study of Metabolizer Phenotyping and Clinical Outcomes." Clinical and Translational Science 19, no. 6 (2026): e70637. https://doi.org/10.1111/cts.70637.
MLA (9th ed.) CitationLC, da Costa-Junior, et al. "Tacrolimus Concentration/Dose Ratio in Hematopoietic Cell Transplantation Recipients: An Exploratory Study of Metabolizer Phenotyping and Clinical Outcomes." Clinical and Translational Science, vol. 19, no. 6, 2026, p. e70637, https://doi.org/10.1111/cts.70637.
